By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today announced it has extended its $85.4 million bid for Orchid Cellmark to 5 p.m. EDT Nov. 4.

It is the seventh time the proposed deal, in which LabCorp will pay $2.80 for each share of Orchid stock, has been extended. It previously had been extended to Oct. 7.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.